Customers' personal AI agents (PAAs) have already arrived, with 56.1% of companies confirming interactions and 83.3% rating those agents' success at resolving issues for their owners as excellent or good. Adoption is expected to accelerate rapidly: not a single study participant believes customers are unlikely to use PAAs, and 72.9% anticipate these agents will account for more than 10% of their customer interactions within a year. Currently, PAAs primarily gather information (68.0%), book appointments (48.0%), and check orders (46.7%), though payment activity varies sharply by sector, occurring at 48.1% of B2C companies compared to just 12.5% of B2B firms. Despite the contact center absorbing these interactions, only 18.8% of organizations grant it accountability, leaving IT to own the response at 62.1% of companies.
Security and governance remain primary hurdles as organizations adapt to this shift. Security is cited as a top-three barrier by 54.8% of companies and is the top priority to resolve first for 39.4%, especially given that 29.1% of companies with confirmed PAA interactions have already uncovered AI agent fraud. In response, 47.5% of companies plan to enforce stricter rules on AI agents than on human customers, while the 14.3% lacking a defined policy face an urgent need to establish one. Although 85.0% of firms report having budget allocated to PAA security and processes, only 32.0% actually know the specific amount.
Overall, 72.9% of organizations view personal AI agents as more of an opportunity than a problem, though skepticism is notably higher in Europe—where 22.2% of leaders see low value—compared to just 3.9% in North America. To navigate this landscape, companies place the most trust in stand-alone AI agent providers (18.5%) and security vendors (14.5%), driven largely by perceived expertise (25.0%) and security capabilities (24.6%). Meanwhile, 59.4% of businesses are already adapting their marketing strategies, with optimizing content and data for AI agent discovery emerging as the leading theme at 22.1%.